Contact

Email

emilio.perucca@unimelb.edu.au

Credentials

Position
Clinical (Professor)
Department of Medicine
Education

University of Pavia
PhD
University of London
Bachelors Degree
University of Pavia
ORCID

0000-0001-8703-223X

Prof Emilio Perucca

Clinical (Professor)
Department of Medicine
721 Scholarly works
1 Projects

HIGHLIGHTS

  • 2027

    Research grants (ARC, NHMRC, MRFF)

    A Master Protocol for PRecision Therapies in Monogenic Epilepsies (PRIME)
  • 2026

    Journal article

    Progress report on new epilepsy treatments: A summary of the Eighteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVIII). II. Treatments in more advanced clinical development.
    DOI: 10.1002/epi.70346
  • 2026

    Journal article

    Drug-treatment changes, depression, and quality of life in adults with drug-resistant focal epilepsy.
    DOI: 10.1002/epi.70356
  • 2026

    Journal article

    Progress report on new epilepsy treatments: A summary of the Eighteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVIII). I. Treatments in preclinical and early clinical development.
    DOI: 10.1002/epi.70354
  • 2026

    Journal article

    Azetukalner, a Novel, Potent KV7 Channel Opener, in Adults with Focal Epilepsy: ≥42-Month Interim Analysis of the Ongoing 7-year X-TOLE Open-label Extension (P11-10.001)
    DOI: 10.1212/wnl.0000000000212924
  • 2026

    Journal article

    Prehospital Treatment of Status Epilepticus (SE) with Diazepam Nasal Spray in Pediatric and Adult Patients with Epilepsy (P1-11.001)
    DOI: 10.1212/wnl.0000000000216286
  • 2026

    Journal article

    Evolution of the European Medicines Agency clinical guidelines for epilepsy drug development between 2010 and 2025: A comparative analysis by the ILAE Task Force on Regulatory Affairs
    DOI: 10.1002/epi.70152
Emilio Perucca

RECENT SCHOLARLY WORKS

  • 2026

    Journal article

    Novel epilepsy treatments in clinical development
    DOI: 10.1016/j.yebeh.2026.110970
  • 2026

    Journal article

    Antiseizure Medications that Did Not Reach the Epilepsy Market: An Assessment of Factors Contributing to Their Failed Clinical Development Over the Last Three Decades
    DOI: 10.1007/s40265-026-02297-y
  • 2026

    Journal article

    Transcription Factor Binding and Individual Genetic Risk of Valproate Teratogenicity
    DOI: 10.1212/WNL.0000000000214570
  • 2026

    Journal article

    Clobazam versus corticosteroid for developmental and epileptic encephalopathy with spike–wave activation in sleep ((D)EE-SWAS): Results of a multicenter observational study
    DOI: 10.1111/epi.18680